Volume 92 Issue 23 | p. 8 | News of The Week
Issue Date: June 9, 2014

Sequence Of Events

Technology: Roche acquires Genia, repositioning itself in the next-generation sequencing race
Department: Business
Keywords: gene sequencing, acquisition, genomics, diagnostics

Roche has acquired Genia Technologies, a privately held gene-sequencing company based in Mountain View, Calif. The Swiss drug and diagnostics company is looking to bolster its standing in the next-generation sequencing field after recent setbacks.

Roche sees its purchase as a step toward introducing “a potentially disruptive technology to the market,” says Roland Diggelmann, chief operating officer of Roche Diagnostics. To do so, Roche is willing to pay Genia’s shareholders $125 . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society